Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-release tacrolimus in kidney transplant recipients
IRCT20230909059387N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2026
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tacrolimus in Kidney allograft status (RTx), sponsored by Shiraz University of Medical Sciences. Started Feb 2026; status: completed.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on IRCT20230909059387N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230909059387N1.